Wed, Aug 20, 2014, 6:54 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

MELA Sciences, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • android_stocks android_stocks Jun 30, 2010 10:49 AM Flag

    Remember: 2010 FDA Advisory Panel Run-Ups Average 66% Gain

    Respectfully disagree.

    Hey, are you in VVUS also?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Yes, I'm in for 1K and some July $12 Calls. I plan on closing both positions before July 12th.

      http://www.BioRunUp.com

      • 1 Reply to bio.runup
      • moriarty.john@rocketmail.com moriarty.john Jun 30, 2010 12:31 PM Flag

        I jumped off that ship at 12.15 in may when the market started having earthquakes...

        As for MELA I wouldn't jump right out and say the offering was a bad thing. Everyone hates them, and yes it is a little fishy.

        However if you give it some thought , the market is getting shaky, and they only have enough cash to last them about 5 quarters. And lets face it, management knows people play the run ups and can sell off. And everyone and their brother knows the housing market is going to tank again.

        So if you knew people sell off after decisions and the market might be headed downward for the next year, and your going to run out of money in a year, wouldn't you secure some cash now? It still gives time for appreciation in the stock price again and they had 2 insider buys in june (not for much though)

        Im going with biorun on this one as long as the over all market doesn't tank before then. which Im 50/50 on. Decent earnings across the sectors could keep the market uneasy but afloat for another quarter. But I'm leery of housing even as a bio guy.

        Anyway just my opinion. GL

 
MELA
2.31-0.10(-4.15%)Aug 20 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.